Jorge Pino, MD
Hospitalist · Birmingham, ALNPI 1447361118
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 51 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 21 manufacturers, the largest accounting for just 15.2% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $225 and has fallen 65.0% since, to $79 in 2025.
Across 51 payments — averaging $19.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$150
- Xeris Pharmaceuticals, Inc.$113
- Sanofi-aventis U.S. LLC$111
- Medtronic$106
- IBSA Pharma Inc.$100
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$79
- plus $329 from 15 others
What the payments were for
- Food & beverage$989100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 10 | $150 |
| Xeris Pharmaceuticals, Inc. | 6 | $113 |
| Sanofi-aventis U.S. LLC | 6 | $111 |
| Medtronic | 1 | $106 |
| IBSA Pharma Inc. | 5 | $100 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 5 | $79 |
| Amgen | 3 | $45 |
| Johnson & Johnson | 1 | $37 |
| Abbott | 2 | $35 |
| Otsuka America Pharmaceutical, Inc. | 1 | $26 |
| Dexcom, Inc. | 1 | $22 |
| OPKO Pharmaceuticals, LLC | 1 | $20 |
| AbbVie | 1 | $19 |
| AstraZeneca | 1 | $18 |
| Amarin Pharma, Inc. | 1 | $18 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $18 |
| Paratek Pharmaceuticals, Inc. | 1 | $15 |
| Senseonics, Incorporated | 1 | $15 |
| Lifescan, Inc. | 1 | $14 |
| Shire North American Group Inc | 1 | $14 |
| Novartis | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- MINIMED 780G$106
How this compares
$989 in reported general payments places this provider in the 80th percentile of 265 hospitalist providers in Alabama.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 19 | $14,996 |
| Levothyroxine Sodium | 22 | $333 |
| Metformin Hcl ErMetformin Hcl | 14 | $331 |
| Atorvastatin Calcium | 36 | $298 |
| Nitroglycerin | 21 | $180 |
| Losartan Potassium | 25 | $173 |
| Hydralazine Hcl | 14 | $116 |
| Carvedilol | 25 | $111 |
| Cefdinir | 13 | $105 |
| Amlodipine Besylate | 22 | $105 |
| Metoprolol Tartrate | 21 | $100 |
| Pantoprazole Sodium | 23 | $92 |
| ClopidogrelClopidogrel Bisulfate | 11 | $69 |
| Furosemide | 16 | $42 |
| Prednisone | 14 | $35 |
Paid to pharmacies, not to this prescriber.
Other hospitalist in Birmingham
- Aftab KhanBirmingham$5K
- Mark CromerBirmingham$4K
- Matthew BurdenBirmingham$4K
- Faheem ShaikhBirmingham$3K
- Sandeep VirkBirmingham$3K
- Laura KukucBirmingham$2K
- Siddharth BansalBirmingham$2K
- Peter HwangBirmingham$1K
- George TisdaleBirmingham$909
- Brandon BringuelBirmingham$875
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.